IR Searcher

基本データ

【業種】: 医薬品
【市場】: スタンダード（内国株式）
【決算期】: 3月
【会社設立】
【上場】: 1995.12
【直近決算日】: 2025-05-09（4Q）
【決算予定日】: 未定

【時価総額】: 56億5300万円
【PBR】: 0.77倍
【配当利回り(予)】: 2.58%

企業概要

同社は、体外診断用医薬品や臨床検査薬、医療機器の製造および販売を主な事業としている。
特に、生化学試薬や免疫学試薬に注力し、腎機能、肝機能、糖尿病検査用の試薬や、輸血・癌マーカーに関連する試薬を展開している。
また、遺伝子検査分野では新型コロナウイルス遺伝子検出試薬や、抗AAV抗体測定キットなどの開発も行っている。
さらに、全自動輸血検査装置の販売により、輸血検査用機器市場にも参入している。
上記のような多様な製品群を通じて、臨床検査における幅広いニーズに応える体制が整っている。

業績修正履歴

年度	タイプ	日付	売上高	営業利益	経常利益	純利益
2023-03	新規	2022-05-09	5,000	800	800	520
	変更	2022-10-13	5,100(⬆)	900(⬆)	900(⬆)	600(⬆)
2024-03	新規	2023-05-10	5,200	850	850	570
2025-03	新規	2024-05-09	5,400	800	800	550
今期	新規	2025-05-09	5,500	850	850	600

通期四半期別

売上高

経常利益

純利益

通期四半期別

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
	予想	5,500	850	850	600	142.33	15.45%	15.45%	3.68%	3.28%	2.66%	-6.40%
2025-03	4	5,305	823	828	641	152.06	15.51%	15.61%	4.9%	-4.8%	-10.8%	0.5%
	3	4,052	670	675	490	116.27	16.54%	16.66%	6.9%	-15.5%	-16.8%	-15.1%
	2	2,670	471	473	347	82.54	17.64%	17.72%	7.3%	-8.9%	-9.8%	-6%
	1	1,296	266	266	187	44.54	20.52%	20.52%	8.9%	27.2%	26.3%	30.5%
2024-03	4	5,056	865	928	637	152.26	17.11%	18.35%	2.7%	5.4%	8.7%	12.3%
	3	3,790	794	811	577	138.01	20.95%	21.4%	1.6%	13.5%	12.3%	16%
	2	2,487	517	525	370	88.66	20.79%	21.11%	-1%	1.3%	-0.4%	3.1%
	1	1,190	209	210	143	34.48	17.56%	17.65%	-4.2%	-28.5%	-29.5%	-28.6%
2023-03	4	4,923	821	853	568	136.13	16.68%	17.33%	6.7%	9.8%	9.8%	10.9%
	3	3,728	699	722	497	119.24	18.75%	19.37%	7.5%	5.7%	7.6%	8.7%
	2	2,512	511	527	358	85.99	20.34%	20.98%	7.8%	15.6%	18.7%	19.2%
	1	1,242	292	298	201	48.28	23.51%	23.99%	6.1%	4.8%	6.1%	4.3%
2022-03	4	4,614	747	777	512	126.39	16.19%	16.84%	8.4%	18.3%	19%	22.7%
	3	3,468	662	671	457	112.65	19.09%	19.35%	9.2%	27.5%	26.8%	34.1%
	2	2,330	442	444	301	73.58	18.97%	19.06%	11.7%	37.9%	36.2%	49.9%
	1	1,170	279	281	193	47.2	23.85%	24.02%	18.3%	73.1%	69.4%	55.3%
2021-03	4	4,257	632	653	417	100.63	14.85%	15.34%	-7.6%	3.9%	6.1%	4.7%
	3	3,174	519	529	341	81.97	16.35%	16.67%	-9.6%	-7.2%	-5.7%	-11.3%
	2	2,086	320	325	200	48.06	15.34%	15.58%	-8.4%	-0.2%	1.4%	-9.2%
	1	989	161	166	124	29.75	16.28%	16.78%	-9.4%	84.3%	86.2%	183%
2020-03	4	4,609	608	616	398	97.09	13.19%	13.37%	-1.3%	4.7%	3.3%	3.3%
	3	3,512	559	561	384	94.23	15.92%	15.97%	-3.4%	-0.5%	-2.9%	-2.4%
	2	2,277	321	321	221	54.76	14.1%	14.1%	1%	4.7%	-1.1%	0.7%
	1	1,091	87	89	43	11.18	7.97%	8.16%	-7.4%	-55.8%	-55.6%	-68.1%
2019-03	4	4,670	581	596	385	98.57	12.44%	12.76%	6.5%	27.4%	25%	38.9%
	3	3,635	562	578	394	98.96	15.46%	15.9%	10.3%	40.2%	37.2%	44.3%
	2	2,254	307	324	219	53.59	13.62%	14.37%	12.4%	89.8%	80.4%	72.9%
	1	1,178	198	201	137	32.98	16.81%	17.06%	19.5%	149.6%	115.7%	134.5%
2018-03	4	4,386	456	477	277	66.49	10.4%	10.88%	-6.7%	-3.9%	2%	-10.3%
	3	3,297	401	422	273	65.35	12.16%	12.8%	-8.6%	-10.8%	-5.1%	-10.1%
	2	2,006	161	180	126	30.38	8.03%	8.97%	-14.8%	-34.1%	-19.9%	-13.4%
	1	985	79	93	58	14.07	8.02%	9.44%	-22.2%	-56.3%	-42%	-31.1%
2017-03	4	4,703	474	468	309	74.12	10.08%	9.95%	-12%	7.3%	6.2%	4.5%
	3	3,609	449	444	303	72.7	12.44%	12.3%	-8.3%	20.8%	17.7%	16.1%
	2	2,356	245	224	146	35.08	10.4%	9.51%	-8.6%	14.3%	0.3%	-6.5%
	1	1,266	182	160	85	20.43	14.38%	12.64%	-2.8%	41.4%	12.5%	-8.4%
2016-03	4	5,345	442	440	296	69.39	8.27%	8.23%	-2.4%	10.2%	12.3%	28.7%
	3	3,935	372	377	261	60.85	9.45%	9.58%	-5.6%	18.6%	18.2%	28.9%
	2	2,577	214	223	156	35.96	8.3%	8.65%	-5.3%	23.7%	31.2%	47.6%
	1	1,302	128	142	93	20.93	9.83%	10.91%	-12.6%	19.7%	32.6%	32.6%

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
2025-03	4	1,253	153	153	151	35.79	12.21%	12.21%	-1.03%	115.49%	30.77%	151.67%
	3	1,382	199	202	143	33.73	14.4%	14.62%	6.06%	-28.16%	-29.37%	-30.92%
	2	1,374	205	207	160	38	14.92%	15.07%	5.94%	-33.44%	-34.29%	-29.52%
	1	1,296	266	266	187	44.54	20.52%	20.52%	8.9%	27.2%	26.3%	30.5%
2024-03	4	1,266	71	117	60	14.25	5.61%	9.24%	5.94%	-41.8%	-10.69%	-15.49%
	3	1,303	277	286	207	49.35	21.26%	21.95%	7.15%	47.34%	46.67%	48.92%
	2	1,297	308	315	227	54.18	23.75%	24.29%	2.13%	40.64%	37.55%	44.59%
	1	1,190	209	210	143	34.48	17.56%	17.65%	-4.2%	-28.5%	-29.5%	-28.6%
2023-03	4	1,195	122	131	71	16.89	10.21%	10.96%	4.28%	43.53%	23.58%	29.09%
	3	1,216	188	195	139	33.25	15.46%	16.04%	6.85%	-14.55%	-14.1%	-10.9%
	2	1,270	219	229	157	37.71	17.24%	18.03%	9.48%	34.36%	40.49%	45.37%
	1	1,242	292	298	201	48.28	23.51%	23.99%	6.1%	4.8%	6.1%	4.3%
2022-03	4	1,146	85	106	55	13.74	7.42%	9.25%	5.82%	-24.78%	-14.52%	-27.63%
	3	1,138	220	227	156	39.07	19.33%	19.95%	4.6%	10.55%	11.27%	10.64%
	2	1,160	163	163	108	26.38	14.05%	14.05%	5.74%	2.52%	2.52%	42.11%
	1	1,170	279	281	193	47.2	23.85%	24.02%	18.3%	73.1%	69.4%	55.3%
2021-03	4	1,083	113	124	76	18.66	10.43%	11.45%	-1.28%	130.61%	125.45%	442.86%
	3	1,088	199	204	141	33.91	18.29%	18.75%	-11.9%	-16.39%	-15%	-13.5%
	2	1,097	159	159	76	18.31	14.49%	14.49%	-7.5%	-32.05%	-31.47%	-57.3%
	1	989	161	166	124	29.75	16.28%	16.78%	-9.4%	84.3%	86.2%	183%
2020-03	4	1,097	49	55	14	2.86	4.47%	5.01%	5.99%	157.89%	205.56%	―
	3	1,235	238	240	163	39.47	19.27%	19.43%	-10.57%	-6.67%	-5.51%	-6.86%
	2	1,186	234	232	178	43.58	19.73%	19.56%	10.22%	114.68%	88.62%	117.07%
	1	1,091	87	89	43	11.18	7.97%	8.16%	-7.4%	-55.8%	-55.6%	-68.1%
2019-03	4	1,035	19	18	-9	-0.39	1.84%	1.74%	-4.96%	-65.45%	-67.27%	―
	3	1,381	255	254	175	45.37	18.46%	18.39%	6.97%	6.25%	4.96%	19.05%
	2	1,076	109	123	82	20.61	10.13%	11.43%	5.39%	32.93%	41.38%	20.59%
	1	1,178	198	201	137	32.98	16.81%	17.06%	19.5%	149.6%	115.7%	134.5%
2018-03	4	1,089	55	55	4	1.14	5.05%	5.05%	-0.46%	120%	129.17%	-33.33%
	3	1,291	240	242	147	34.97	18.59%	18.75%	3.03%	17.65%	10%	-6.37%
	2	1,021	82	87	68	16.31	8.03%	8.52%	-6.33%	30.16%	35.94%	11.48%
	1	985	79	93	58	14.07	8.02%	9.44%	-22.2%	-56.3%	-42%	-31.1%
2017-03	4	1,094	25	24	6	1.42	2.29%	2.19%	-22.41%	-64.29%	-61.9%	-82.86%
	3	1,253	204	220	157	37.62	16.28%	17.56%	-7.73%	29.11%	42.86%	49.52%
	2	1,090	63	64	61	14.65	5.78%	5.87%	-14.51%	-26.74%	-20.99%	-3.17%
	1	1,266	182	160	85	20.43	14.38%	12.64%	-2.8%	41.4%	12.5%	-8.4%
2016-03	4	1,410	70	63	35	8.54	4.96%	4.47%	7.72%	-19.54%	-13.7%	29.63%
	3	1,358	158	154	105	24.89	11.63%	11.34%	―	―	―	―
	2	1,275	86	81	63	15.03	6.75%	6.35%	―	―	―	―
	1	1,302	128	142	93	20.93	9.83%	10.91%	-12.6%	19.7%	32.6%	32.6%

4556 カイノス 企業サイト Yahooファイナンス 日経新聞 株探 四季報

4556 カイノス　企業サイト　　　Yahooファイナンス　日経新聞　株探　四季報　